Associate Principal Scientist
Astrazeneca, United Kingdom
Philip gained his undergraduate degree at Leeds University prior to completing a Masters at Edinburgh University in Immunology. After working at Manchester University for several years in the areas of DNA damage and drug efflux he joined AstraZeneca in 2001 in the Cancer and Infection department, focusing on Oncology projects spanning the drug discovery timeline, from Hit Identification to Lead Optimisation and Candidate Drug nomination. During this time he was introduced to the world of automation. On formation of the Discovery Sciences department he has focused on cell assay development, profiling and mode of action studies, with a particular specialism/interest in high content imaging. He is heavily involved in driving the use/uptake of automation in cellular assays, leading a cross functional team of automation superusers. He was instrumental in planning the build of new automated systems to ‘future proof’ delivery on the move to the DISCovery Centre in Cambridge (UK).